Symptoms are an important outcome in chronic obstructive pulmonary disease clinical trials: results of a 3-month comparative study using the Breathlessness, Cough and Sputum Scale... von Celli, B., Halpin, D., Hepburn, R., Byrne, N., Keating, E.T., Goldman, M.

Volltext

Conclusion lessons from the novel D 2 dopamine receptor, β 2-adrenoceptor agonist, Viozan™: chronic obstructive pulmonary disease and drug development implications von Calverley, P., Keating, E.T., Goldman, M., Casty, F.

Volltext

Conclusion lessons from the novel D2 dopamine receptor, [beta]2-adrenoceptor agonist, Viozan(TM): chronic obstructive pulmonary disease and drug development implications von Calverley, P, Keating, E.T, Goldman, M, Casty, F

Volltext

Conclusion lessons from the novel D2 dopamine receptor, β2-adrenoceptor agonist, Viozan™: chronic obstructive pulmonary disease and drug development implications von Calverley, P., Keating, E.T., Goldman, M., Casty, F.

Volltext

Effects of the phase-separated melt on crystallization behavior and morphology in short chain branched metallocene polyethylenes von Fu, Qiang, Chiu, Fang-Chyou, McCreight, Kevin W., Guo, Mingming, Tseng, Wen W., Cheng, Stephen Z. D., Keating, Mimi Y., Hsieh, Eric T., DesLauriers, Paul J.

Volltext